Severe preeclampsia in postpartum patients. Severe pre-eclampsia
Conditions
Interventions
Intervention 1: First intervention group: 250 mg methyl dopamine 250 mg every 8 hours manufactured by Zahravi Pharmaceutical Company for up to one week. Intervention 2: Second Intervention group: 40 m
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patient with preeclampsia. Patient has been treated by Mgso4 The patient's blood pressure is between 140/90 to 160/100.
Exclusion criteria
Exclusion criteria: Patient has gestational diabetes. Patient has heart disease. Patient has renal disease. Patient has allergic reaction to lasix. Patient has allergic reaction to methyldopa.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The measure of patient's Systolic blood pressure that should be between 140 to 160 mm Hg. Timepoint: Blood pressure measurement in the first 24 hours after the intervention and in the second 24 hours after the intervention, and then a week later. Method of measurement: Mercury barometric device.;The measure of patient's diastolic blood pressure that should be between 90 to 100 mm Hg. Timepoint: Blood pressure measurement in the first 24 hours after the intervention and in the second 24 hours after the intervention, and then a week later. Method of measurement: Mercury barometric device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSetareh Siahmansoori
Iran University of Medical Sciences
Outcome results
None listed